Patient Safety: What 795 Doesn't Talk About | September 23, 2024
POWERED BY LP3 NETWORK
This webinar will be live on September 23rd, 2024 at 7:00pm Eastern Daylight Time (EDT).
Overview
The revisions to USP 795 have provided more structure and specificity about what is needed in nonsterile compounding. However, there are a number of areas where you as the compounder have to make decisions, define your procedures, and ultimately be able to provide justification for your choices. We will investigate these areas, resources that exist within USP, and the criteria to consider in making your decisions.
Intended audience
- Pharmacists & Pharmacy Technicians
Learning Objectives
Pharmacists and Pharmacy Technicians
- Analyze USP 795 to determine the topics that need further discussion for policy and procedure development.
- Establish criteria to consider when making decisions on implementing policy that influences the quality of nonsterile compounded medications.
- Identify USP resources beyond chapter 795 that can be utilized to create a culture of quality for nonsterile compounding.
Hardware/software requirements
We will be using Zoom for this webinar - full system requirements can be found here. You can download the Zoom client here.
Web browser |
| ||
Internet connection |
| ||
Misc |
| ||
Hardware | Minimum | Recommended | |
Processor | Single-core 1Ghz or higher | Dual-core 2Ghz or higher (Intel i3/i5/i7 or AMD equivalent) | |
RAM | N/A | 4 GB |
COPYRIGHT
This webinar is Copyright © Alliance for Pharmacy Compounding 2024.
Matt Martin, PharmD, BCSCP |
Matt Martin, PharmD, BCSCP, joined the PCCA Clinical Services team in September 2014 and now serves as Director of Clinical Services.
He graduated from Morehead State University with a BS in Chemistry in 2002 and received his PharmD from the University of Kentucky College of Pharmacy in 2006. In 2020, Matt became board certified in Compounded Sterile Preparations through the Board of Pharmacy Specialties.
Prior to joining the PCCA team, Matt worked in compounding pharmacy for more than eight years and has experience with both sterile and non-sterile preparations.
This activity is eligible for ACPE credit; see final CPE activity announcement for specific details.